We host and provide state-of-art technologies to ~300 scientists, doctors, nutritionists and pharmaceutical scientists, working collaboratively in four overarching research domains.
Our focus areas
Our research encompasses four focuses: Vascular and Metabolic Disorders; Inflammation, Infectious Disease and Wounds; Neurodegenerative Disorders; and Cancer.
Vascular and Metabolic Disorders
We are identifying new treatments for blood vessel disorders including bleeding and clotting disorders, heart disease and stroke, and investigating blood vessel growth and function to treat age-associated cancers, blood-vessel inflammatory disorders, energy disorders, liver disorders and infectious diseases.
Learn more:
Our Vascular and Metabolic Disorders research
Our Vascular and Metabolic Disorders key people
Inflammation, Infectious Disease & Wound
We are developing ways to stop the decline in immune system function with ageing, using the immune system to treat arthritis and adult cancers.
Learn more:
Our Inflammation, Infectious Disease & Wounds research
Our Inflammation, Infectious Disease & Wounds key people
Neurodegenerative and Pain
We are exploring new approaches for preventing and treating Alzheimer’s disease, where we’re hoping to slow cognitive decline significantly.
Learn more:
Our Neurodegenerative and Pain research
Our Neurodegenerative and Pain key people
Cancer
We’re researching interventions for age-associated cancers such as breast, pancreas and prostate cancer and melanoma, focusing on how the immune system influences cancer risk and disease progression.
Learn more: